Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The UConn/JAX-GM Training Program in Genomic Science
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
Age/Nutrition/Genes in Models of Psychiatric Disorders
Xray Data Collection of RNA Polymerase II & DNA CO Crystal
Gene Structure and Function in the Rat Seminal Vesicle
Recently added grants:
A Long Noncoding RNA Amerliorates Periodontitis via Distinct Epigenetic Pathways
Risk and strength: determining the impact of area-level racial bias and protective factors on birth outcomes.
Development of PET imaging probes for ROCK2
Molecular mechanisms underlying cortical interneuron synaptic specificity
Regulation of spore peptidoglycan modification
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67185-2-0-1
Application #
7574879
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ University of Colorado Denver
$385,356
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Badesch, David /
$360,397
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant